MacKinnon J R, McKillop G, O'Brien C, Swa K, Butt Z, Nelson P
Princess Alexandra Eye Pavilion, Royal Infirmary of Edinburgh NHS Trust, Scotland.
Acta Ophthalmol Scand. 2000 Aug;78(4):386-9. doi: 10.1034/j.1600-0420.2000.078004386.x.
To measure blood flow velocity in the ophthalmic artery (OA) and central retinal artery (CRA) in patients with diabetic retinopathy.
62 age-matched subjects divided into 3 groups: nondiabetic controls (n=17); diabetics with no clinical retinopathy or background changes (n=24); diabetics with either pre-proliferative or proliferative retinopathy (n=21). Colour Doppler imaging was performed on supine patients by one masked observer using the Acuson 128 machine.
There was a statistically significant (p<0.05) decrease in both the peak systolic velocity (PSV 0.073 m/s) and end diastolic velocity (EDV 0.014 m/s) of the central retinal artery in the pre-proliferative/proliferative group compared to the no retinopathy/background retinopathy group (PSV 0.096 m/s, EDV 0.024 m/s) and the control group (PSV 0.142 m/s, EDV 0.029 m/s). The resistance index of the ophthalmic artery was significantly increased in both the preproliferative/proliferative (0.81) and the no retinopathy/background group (0.81) compared to controls (0.72).
Reduced blood flow velocity was found in the CRA of diabetic patients and appeared to become further reduced with the progression of retinopathy. This suggests that monitoring with Colour Doppler imaging may have predictive power in identifying those at greatest risk of developing sight threatening proliferative disease. The resistance index of the OA was increased in diabetics compared to controls.
测量糖尿病视网膜病变患者眼动脉(OA)和视网膜中央动脉(CRA)的血流速度。
62名年龄匹配的受试者分为3组:非糖尿病对照组(n = 17);无临床视网膜病变或仅有背景改变的糖尿病患者(n = 24);患有增殖前期或增殖性视网膜病变的糖尿病患者(n = 21)。由一名经过培训的观察者使用Acuson 128机器对仰卧位患者进行彩色多普勒成像检查。
与无视网膜病变/背景性视网膜病变组(收缩期峰值速度[PSV] 0.096 m/s,舒张末期速度[EDV] 0.024 m/s)和对照组(PSV 0.142 m/s,EDV 0.029 m/s)相比,增殖前期/增殖性视网膜病变组的视网膜中央动脉收缩期峰值速度(PSV 0.073 m/s)和舒张末期速度(EDV 0.014 m/s)均有统计学意义的降低(p < 0.05)。与对照组(0.72)相比,增殖前期/增殖性视网膜病变组(0.81)和无视网膜病变/背景性视网膜病变组(0.81)的眼动脉阻力指数均显著升高。
糖尿病患者的视网膜中央动脉血流速度降低,且随着视网膜病变的进展似乎进一步降低。这表明彩色多普勒成像监测可能对识别发生威胁视力的增殖性疾病风险最高的患者具有预测价值。与对照组相比,糖尿病患者的眼动脉阻力指数升高。